pBp-FGFR2c-WT Citations (5)

Originally described in: Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.
Liao RG, Jung J, Tchaicha JH, Wilkerson MD, Sivachenko A, Beauchamp EM, Liu Q, Pugh TJ, Pedamallu CS, Hayes DN, Gray NS, Getz G, Wong KK, Haddad RI, Meyerson M, Hammerman PS Cancer Res. 2013 Jun 20. PubMed Journal

---

Articles Citing pBp-FGFR2c-WT

Articles
Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition. Ranieri D, Rosato B, Nanni M, Magenta A, Belleudi F, Torrisi MR. Oncotarget. 2016 Feb 2;7(5):5440-60. doi: 10.18632/oncotarget.6706. PubMed
Composition of receptor tyrosine kinase-mediated lipid micro-domains controlled by adaptor protein interaction. Rohwedder A, Knipp S, Roberts LD, Ladbury JE. Sci Rep. 2021 Mar 17;11(1):6160. doi: 10.1038/s41598-021-85578-8. PubMed
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy. Lei JH, Lee MH, Miao K, Huang Z, Yao Z, Zhang A, Xu J, Zhao M, Huang Z, Zhang X, Chen S, Jiaying NG, Feng Y, Xing F, Chen P, Sun H, Chen Q, Xiang T, Chen L, Xu X, Deng CX. Adv Sci (Weinh). 2021 Nov;8(21):e2100974. doi: 10.1002/advs.202100974. Epub 2021 Sep 13. PubMed
HiFENS: high-throughput FISH detection of endogenous pre-mRNA splicing isoforms. Shilo A, Pegoraro G, Misteli T. Nucleic Acids Res. 2022 Dec 9;50(22):e130. doi: 10.1093/nar/gkac869. PubMed
SB Digestor: a tailored driver gene identification tool for dissecting heterogeneous Sleeping Beauty transposon-induced tumors. Zhang A, Wang L, Lei JH, Miao Z, Valecha MV, Hu P, Miao K, Deng CX. Int J Biol Sci. 2023 Mar 13;19(6):1764-1777. doi: 10.7150/ijbs.81317. eCollection 2023. PubMed

If you have published an article using this material, please email us at to have your article added to this page.